한국바이오젠(주)

매출

6,240,223,694

12,325,284,027

6,435,966,938

12,971,608,988

매출원가

3,988,352,359

8,425,812,164

3,888,636,777

8,260,358,392

매출총이익

2,251,871,335

3,899,471,863

2,547,330,161

4,711,250,596

판매비와관리비

1,128,586,026

2,254,936,787

875,182,724

1,812,118,959

영업이익

1,123,285,309

1,644,535,076

1,672,147,437

2,899,131,637

기타수익

165,981,291

179,338,631

14,689,968

30,285,257

기타비용

12,146,002

58,205,190

15,043,277

30,958,126

금융수익

140,896,552

255,635,608

247,141,202

548,541,662

금융비용

172,378,776

251,347,002

99,829,925

122,468,399

법인세비용차감전순이익

1,245,638,374

1,769,957,123

1,819,105,405

3,324,532,031

법인세비용

160,513,266

191,465,062

356,450,378

635,164,541

반기순이익

1,085,125,108

1,578,492,061

1,462,655,027

2,689,367,490

기타포괄손익

(1,518,287)

(2,900,664)

(35,027,384)

(63,171,412)

　후속적으로 당기손익으로 재분류되지 않는 포괄손익

(1,518,287)

(2,900,664)

(35,027,384)

(63,171,412)

　　순확정급여채무의 재측정요소

(1,518,287)

(2,900,664)

(35,027,384)

(63,171,412)

반기총포괄이익

1,083,606,821

1,575,591,397

1,427,627,643

2,626,196,078

반기순이익의 귀속

　지배기업소유주

1,085,125,108

1,578,492,061

1,462,655,027

2,689,367,490

　비지배지분

0

0

0

0

반기총괄이익의 귀속

　지배기업소유주

1,083,606,821

1,575,591,397

1,427,627,643

2,626,196,078

　비지배지분

0

0

0

0

주당이익

　기본주당이익 (단위 : 원)

125

181

168

309

　희석주당이익 (단위 : 원)

125

181

168

309